Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Positive effects on aggressive behavior and learning reported for NVP-SRA-880

July 15, 2002

Ligands for EAATs identified in series of 5-methylglutamate analogues

July 15, 2002

Antiplatelet/antithrombotic efficacy demonstrated for P2Y12 receptor antagonists

July 15, 2002

MetaPhore's lead SOD mimetics effective in animal models of pain and asthma

July 15, 2002

Russian researchers investigate profile of himantane, a potential new agent for Parkinson's disease

July 15, 2002

Rosuvastatin reported to be effective and suitable for different patient populations

July 12, 2002

Topical therapeutic AIDS vaccine demonstrates antiviral efficacy in monkeys

July 12, 2002

Selective CCK2 antagonist undergoes clinical evaluation at JB for pancreatic cancer

July 12, 2002

Central nAChR agonists show cognition-enhancing and analgesic effects

July 12, 2002

Newly discovered H3 antagonist described in further detail by Abbott

July 12, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...